Haoxi Health Technology Ltd
1 hedge funds and large institutions have $17.4K invested in Haoxi Health Technology Ltd in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
0.22% less ownership
Funds ownership: 0.87% → 0.66% (-0.22%)
30% less capital invested
Capital invested by funds: $24.7K → $17.4K (-$7.34K)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$5.9K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$3.25K |
HAO Hedge Fund Activity: Q3 2025 in Review
1 of the 7,641 institutional investors tracked by Wall St. Rank reported a position in Haoxi Health Technology Ltd (HAO) for Q3 2025, worth a combined $17.4K — down 30% from $24.7K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of HAO and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $5.9K sold.
- 1 institutional investor held Haoxi Health Technology Ltd (HAO) as of Q3 2025, down from 2 in Q2 2025.
- Funds reported $17.4K of Haoxi Health Technology Ltd stock for Q3 2025, down 30% quarter-over-quarter.
- 0 funds opened new Haoxi Health Technology Ltd positions in Q3 2025 and 1 closed out, a net change of -1 holder.
- The largest Haoxi Health Technology Ltd seller in Q3 2025 was UBS Group, an estimated $5.9K sold.
Based on aggregated 13F filings for Q3 2025.